Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 2102043
Publisher
Wiley
Online
2021-08-07
DOI
10.1002/advs.202102043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment
- (2019) Wang Manni et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Immunogenic cell death in cancer therapy: Present and emerging inducers
- (2019) Jingyi Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy
- (2019) Sun-Young Kim et al. ACS Nano
- Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
- (2019) Xianguang Bai et al. OncoTargets and Therapy
- Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
- (2019) Chanyoung Song et al. Nature Communications
- Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
- (2018) Jiayi Yu et al. Journal of Hematology & Oncology
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree
- (2018) Mee Rie Sheen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
- (2018) Lilla Hornyák et al. Frontiers in Immunology
- TGF-β in T Cell Biology: Implications for Cancer Immunotherapy
- (2018) Amina Dahmani et al. Cancers
- Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
- (2018) Qiang Wang et al. CANCER LETTERS
- The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
- (2018) Xiaohong Cen et al. Frontiers in Pharmacology
- Degradation-Regulatable Architectured Implantable Macroporous Scaffold for the Spatiotemporal Modulation of Immunosuppressive Microenvironment and Enhanced Combination Cancer Immunotherapy
- (2018) Long Ren et al. ADVANCED FUNCTIONAL MATERIALS
- Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
- (2018) Hanne Locy et al. Frontiers in Immunology
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants
- (2016) Alyson J. Smith et al. VACCINE
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Targeting the indoleamine 2,3-dioxygenase pathway in cancer
- (2015) Yong Wha Moon et al. Journal for ImmunoTherapy of Cancer
- Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
- (2015) Anna Barbuti et al. Cancers
- Distinct Pathways of Humoral and Cellular Immunity Induced with the Mucosal Administration of a Nanoemulsion Adjuvant
- (2014) A. U. Bielinska et al. JOURNAL OF IMMUNOLOGY
- The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
- (2013) John P Vasilakos et al. Expert Review of Vaccines
- Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- (2012) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
- (2009) Michele Pellegrini et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation